Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DECITABINE Cause Malignant neoplasm progression? 56 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Malignant neoplasm progression have been filed in association with DECITABINE (Decitabine). This represents 1.9% of all adverse event reports for DECITABINE.

56
Reports of Malignant neoplasm progression with DECITABINE
1.9%
of all DECITABINE reports
15
Deaths
15
Hospitalizations

How Dangerous Is Malignant neoplasm progression From DECITABINE?

Of the 56 reports, 15 (26.8%) resulted in death, 15 (26.8%) required hospitalization, and 2 (3.6%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DECITABINE. However, 56 reports have been filed with the FAERS database.

What Other Side Effects Does DECITABINE Cause?

Febrile neutropenia (336) Off label use (292) Drug ineffective (253) Pneumonia (243) Myelosuppression (233) Product use in unapproved indication (195) Neutropenia (193) Sepsis (175) Acute myeloid leukaemia (172) Thrombocytopenia (170)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which DECITABINE Alternatives Have Lower Malignant neoplasm progression Risk?

DECITABINE vs DEFERASIROX DECITABINE vs DEFERIPRONE DECITABINE vs DEFEROXAMINE DECITABINE vs DEFIBROTIDE DECITABINE vs DEFLAZACORT

Related Pages

DECITABINE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression DECITABINE Demographics